| DB ID | MyCo_3286 |
| Title | Anti-PD-L1 peptide improves survival in sepsis |
| Year | 2017 |
| PMID | 27993215 |
| Fungal Diseases involved | Candida sepsis |
| Disease | Candidiasis (Candida Infection) |
| Associated Medical Condition | Sepsis |
| Genus | Candida |
| Species | albicans |
| Organism | Candida albicans |
| Ethical Statement | Procedures were approved by the Animal Studies Committee at Washington University School of Medicine. |
| Site of Infection | Unspecified |
| Opportunistic invasive | None |
| Sample type | None |
| Sample source | NA |
| Host Group | Animal |
| Host Common name | Mice |
| Host Scientific name | Mus musculus |
| Biomarker Name | Anti-PD-L1 peptide-Compound 8 |
| Biomarker Full Name | Anti-PD-L1 peptide-Compound 8 |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | USA |
| Cohort | Six- to eight-week-old male CD1 mice were purchased from Charles River Laboratories (Wilmington, MA, USA) and used in the study. |
| Cohort No. | None |
| Age Group | None |
| P Value | p=0.015 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | 2 fold |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | Flow cytometry |
| Technique | Cell-based Assay |
| Analysis Method | Flow Cytometry Analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Flow Cytometry Analysis |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
